FPHAX Mutual Fund Price & Analysis

This fund typically allocates a minimum of 80% of its capital to entities involved in the pharmaceutical sector, encompassing activities from scientific discovery and development to manufacturing and distribution of various medicinal products. Its holdings include both domestic and international companies, with the portfolio primarily consisting of common equities. Investment decisions are guided by a thorough fundamental analysis, assessing aspects like a company's financial health, its standing within the industry, and broader market and economic trends. It operates as a non-diversified portfolio.

FPHAX Mutual Fund Chart & Stats

$33.27

$0.38(1.16%)

Jun 23, 2026

―

FPHAX Mutual Fund News

PremiumThe Fly

Merck initiated with an Outperform at CICC

11h ago

MRK

PremiumMarket News

Eli Lilly (LLY) to Launch Weight-Loss Pill in Europe Next Year

16h ago

LLY

PremiumThe Fly

Sangamo files for restructuring, plans asset sales to Lilly, Astellas

19h ago

LLY

SGMO

PremiumBlurbs

Analysts Offer Insights on Healthcare Companies: Galectin Therapeutics (GALT) and Gilead Sciences (GILD)

19h ago

GALT

GILD

FPHAX Mutual Fund Smart Score

Outperform

Analyst Consensus

Strong Buy

Average Price Target:
40.73 (― Downside)

Crowd Wisdom

Negative

Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.6%

Learn more about TipRanks Smart Score

For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.